Top Story

Eureka launches phase 1/2 trial of novel T-cell therapy for liver cancer

August 7, 2019

Pexa-Vec trial for liver cancer ends after ‘disappointing’ interim results

August 7, 2019
SillaJen announced the discontinuation of a phase 3 trial designed to evaluate Pexa-Vec for the treatment of advanced liver cancer after interim analysis by the…
FDA News

FDA grants breakthrough therapy designation to Keytruda-Lenvima combination for hepatocellular carcinoma

July 23, 2019
The FDA granted breakthrough therapy designation to pembrolizumab in combination with lenvatinib as first-line treatment for patients with advanced unresectable…

AASLD Foundation presents grants to young hepatologists for research, careers

July 18, 2019
The American Association for the Study of Liver Diseases Foundation has granted $3.42 million in research and career development awards to 29 researchers and clinicians…
More Headlines »
Healio Jobs